Laboratory of Ocular Cell Biology and Visual Science, Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):22. doi: 10.1167/iovs.62.2.22.
Galectin-1/LGALS1, a β-galactoside-binding protein, contributes to angiogenesis and fibrosis in various ocular diseases. Hypoxia-dependent and -independent pathways upregulate galectin-1/LGALS1 expression in Müller glial cells. Here, we present novel findings on the galectin-1/LGALS1 regulatory system in human retinal pigment epithelium (RPE) cells, the major cellular participant in the pathogenesis of neovascular age-related macular degeneration (nAMD).
Human RPE cells were used to evaluate changes in gene and protein expression with real-time quantitative PCR and immunoblot analyses, respectively. The promoter and enhancer regions of LGALS1 were analyzed by reporter assay and chromatin immunoprecipitation. Immunofluorescence analysis of nAMD patient specimens was used to confirm the in vitro findings.
Hypoxia induced galectin-1/LGALS1 expression via binding of hypoxia-inducible factor 1α (HIF-1α) to hypoxia-responsive elements in the LGALS1 promoter region. Blockade of vascular endothelial growth factor receptor 1 (VEGFR1) partially decreased hypoxia-induced galectin-1/LGALS1 expression. Among several VEGFR1 ligands induced by hypoxia, placental growth factor (PlGF)/PGF alone upregulated galectin-1/LGALS1 expression via phosphorylation of activator protein 1 (AP-1) subunits following AKT and p38 mitogen-activated protein kinase (MAPK) activation. An AP-1 site in the LGALS1 enhancer region was required for PlGF-induced galectin-1/LGALS1 expression in RPE cells. PlGF application upregulated PGF expression via extracellular signal-regulated kinase 1 and 2, AKT, and p38 MAPK pathways. nAMD patient specimens demonstrated co-localization of galectin-1 with HIF-1α, PlGF, and VEGFR1 in RPE cells.
Our present findings implicate the significance of hypoxia as a key inducer of galectin-1/LGALS1 in RPE cells and the autoinduction of hypoxia-induced PlGF as a vicious cycle amplifying the pathogenesis of nAMD.
半乳糖凝集素-1(Galectin-1/LGALS1)是一种β-半乳糖苷结合蛋白,它在多种眼部疾病的血管生成和纤维化中发挥作用。缺氧依赖性和非依赖性途径可上调 Müller 胶质细胞中 Galectin-1/LGALS1 的表达。在这里,我们介绍了人视网膜色素上皮(RPE)细胞中 Galectin-1/LGALS1 调节系统的新发现,RPE 细胞是新生血管性年龄相关性黄斑变性(nAMD)发病机制中的主要细胞参与者。
用人 RPE 细胞通过实时定量 PCR 和免疫印迹分析分别评估基因和蛋白表达的变化。通过报告基因分析和染色质免疫沉淀分析分析 LGALS1 的启动子和增强子区域。使用 nAMD 患者标本的免疫荧光分析来证实体外研究结果。
缺氧通过缺氧诱导因子 1α(HIF-1α)与 LGALS1 启动子区域的缺氧反应元件结合诱导 Galectin-1/LGALS1 表达。血管内皮生长因子受体 1(VEGFR1)的阻断部分降低了缺氧诱导的 Galectin-1/LGALS1 表达。在缺氧诱导的几种 VEGFR1 配体中,胎盘生长因子(PlGF)/PGF 单独通过 AKT 和 p38 丝裂原活化蛋白激酶(MAPK)激活后激活蛋白 1(AP-1)亚基的磷酸化,上调 Galectin-1/LGALS1 表达。在 RPE 细胞中,LGALS1 增强子区域的一个 AP-1 位点是 PlGF 诱导的 Galectin-1/LGALS1 表达所必需的。PlGF 应用通过细胞外信号调节激酶 1 和 2、AKT 和 p38 MAPK 途径上调 PGF 表达。nAMD 患者标本显示 Galectin-1 与 HIF-1α、PlGF 和 VEGFR1 在 RPE 细胞中的共定位。
我们的研究结果表明,缺氧作为 RPE 细胞中 Galectin-1/LGALS1 的关键诱导物的重要性,以及缺氧诱导的 PlGF 的自诱导作为放大 nAMD 发病机制的恶性循环。